Description
GLP3-R, known scientifically as Retatrutide, represents the latest advancement in peptide research. As a “Triple Agonist,” this peptide is unique in its ability to simultaneously target three distinct receptor sites: the Glucagon-like peptide-1 (GLP-1), Glucose-dependent insulinotropic polypeptide (GIP), and Glucagon receptors.
Research Applications Our GLP3-R is synthesized for high-stability laboratory research. It is commonly utilized in studies regarding metabolic regulation and receptor binding efficacy.
Quality Assurance Each batch of GLP3-R undergoes rigorous third-party testing. We ensure free-from contaminants and verified peptide content.
FOR RESEARCH USE ONLY:
This product is sold strictly as a chemical reference standard for in-vitro laboratory research purposes only. It is not intended for human or animal consumption, injection, or administration of any kind. This product is not intended to diagnose, treat, cure, or prevent any disease or medical condition. Bodily introduction into humans or animals is strictly prohibited. For use by qualified research professionals only.
GLP3-R (Retatrutide) is a cutting-edge triple agonist peptide designed to target GLP-1, GIP, and Glucagon receptors simultaneously. Our lyophilized powder offers >99% purity, verified by third-party HPLC testing for maximum research reliability. This product is strictly intended for laboratory research and development purposes and is not for human or animal consumption.
